...
首页> 外文期刊>Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie >Plasma metabonomics study of the patients with acute anterior uveitis based on ultra-performance liquid chromatography-mass spectrometry
【24h】

Plasma metabonomics study of the patients with acute anterior uveitis based on ultra-performance liquid chromatography-mass spectrometry

机译:基于超高效液相色谱-质谱法的急性前葡萄膜炎患者血浆代谢组学研究

获取原文
获取原文并翻译 | 示例

摘要

Background: The identification of the biomarkers of patients with acute anterior uveitis (AAU) may allow for a less invasive and more accurate diagnosis, as well as serving as a predictor in AAU progression and treatment response. The aim of this study was to identify the potential biomarkers and the metabolic pathways from plasma in patients with AAU. Methods: Both plasma metabolic biomarkers and metabolic pathways in the AAU patients versus healthy volunteers were investigated using ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) and a metabonomics approach. The principal component analysis (PCA) was used to separate AAU patients from healthy volunteers as well as to identify the different biomarkers between the two groups. Metabolic compounds were matched to the KEGG, METLIN, and HMDB databases, and metabolic pathways associated with AAU were identified. Results: The PCA for UPLC-MS data shows that the metabolites in AAU patients were significantly different from those of healthy volunteers. Of the 4,396 total features detected by UPLC-MS, 102 features were significantly different between AAU patients and healthy volunteers according to the variable importance plot (VIP) values (greater than two) of partial least squares discriminate analysis (PLS-DA). Thirty-three metabolic compounds were identified and were considered as potential biomarkers. Meanwhile, ten metabolic pathways were found that were related to the AAU according to the identified biomarkers. Conclusions: These data suggest that metabolomics study can identify potential metabolites that differ between AAU patients and healthy volunteers. Based on the PCA, PLS-DA, several potential metabolic biomarkers and pathways in AAU patients were found and identified. In addition, the UPLC-MS technique combined with metabonomics could be a suitable systematic biology tool in research in clinical problems in ophthalmology, and can provide further insight into the pathophysiology of AAU.
机译:背景:对急性前葡萄膜炎(AAU)患者的生物标志物的鉴定可能有助于降低侵入性和更准确的诊断,并可以作为AAU进展和治疗反应的预测指标。这项研究的目的是确定AAU患者的潜在生物标志物和血浆中的代谢途径。方法:使用超高效液相色谱-质谱(UPLC-MS)和代谢组学方法研究了AAU患者与健康志愿者的血浆代谢生物标志物和代谢途径。主成分分析(PCA)用于将AAU患者与健康志愿者分开,并识别两组之间的不同生物标志物。代谢化合物与KEGG,METLIN和HMDB数据库匹配,并确定了与AAU相关的代谢途径。结果:用于UPLC-MS数据的PCA显示,AAU患者的代谢产物与健康志愿者的代谢产物显着不同。通过UPLC-MS检测到的4,396个总特征中,根据偏最小二乘判别分析(PLS-DA)的可变重要性图(VIP)值(大于2),AAU患者和健康志愿者之间的102个特征存在显着差异。鉴定了33种代谢化合物,被认为是潜在的生物标志物。同时,根据鉴定出的生物标记物,发现了十条与AAU相关的代谢途径。结论:这些数据表明,代谢组学研究可以鉴定出在AAU患者和健康志愿者之间可能存在差异的潜在代谢产物。基于PCA,PLS-DA,在AAU患者中发现并鉴定了几种潜在的代谢生物标记物和途径。此外,将UPLC-MS技术与代谢组学相结合可能是研究眼科临床问题的合适系统生物学工具,并且可以提供对AAU病理生理学的进一步了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号